🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Enjoyed reflecting on the last decade in Digital Health with Vijay Pande. It's a remarkably different landscape from when I founded Omada Health and from when a16z invested in our business (pre Bio + Health fund). Thanks for having me!

Ever wonder if you’re part of the 1 in 10 commercially insured individuals that have Omada Health as a benefit? Big news. Now you can find out on Amazon. 🎉 Thrilled to this morning announce that Omada is Amazon’s launch partner in their new Health Conditions Programs

🎉 Annoucing Omada as the GLP-1 companion via ESI’s EncircleRx. We’re all very proud of this — innovative combination of technology, services, and PBM administration; ease and simplicity for employers; unique financial model for the offering via ESI; set up for scale and

Congrats to the team Omada Health on our 28th peer-reviewed publication: this one for our type 2 diabetes program, demonstrating long-term A1C reduction and weight maintenance. 🎉

Thank you Rep. Diana DeGette! Expanding access to ##diabetes prevention programs via video and online programs recognized by the CDC will help address the epidemic of pre-diabetes in the #Medicare population. Sean Duffy Omada Health

A blast joining you, Stephen Kraus

AI API Is multimodal AI the superapp of the West? The WeChat equivalent, except driven by text, voice, and camera rather than buttons and menus? Are apps dead? I don’t know if that’s right. I think apps endure and AI drives them. Every app just gets an “AI API” that

If my kiddo wants to talk with GPT-4o as part of her bedtime routine today, where will we be 5 years from now? The true transformations will all be about pragmatic, realistic, centered adoption.

With GLP meds like Ozempic, Wegovy, and Mounjaro making headlines, we’re launching a 3-part series diving deep on Raising Health. First up: Carolyn B Jasik, MD, CMO at Omada Health, on GLP-1s' benefits for weight loss, heart, kidney, liver conditions, and even addiction. Plus, we chat on

Great news! Omada Health has received 4 more years of ADCES DEAP accreditation! What does this mean? We employ an evidence-based clinical approach, and our team maintains a commitment to quality. Learn more about why accreditations matter: buff.ly/3UIv2xK

Exciting news! Omada Health announces a pledge to the Healthcare AI Commitments to support harmonization of standards for health AI. Our goal? Empower human-led care teams with AI that respects member privacy and safety. Learn more in the release: buff.ly/3ziDAEk

As an early investor, I'm so proud to see the company focus on value rather than just valuation. H/T Sean Duffy

Welcome to the team, Sachin H. Jain, MD, MBA (Sachin Jain), Julie Klapstein, and Adam Stavisky. We’re excited to have you all. :)

GLP-1s are not just for diabetes and obesity anymore. Join our CMO Carolyn B Jasik, MD and Mercer Clinical Pharmacist @Ketan Patel, PharmD to: 👉 Explore emerging GLP-1 indications 👉 Implications for health cost 👉 Prepare for benefits planning in 2025 RSVP: buff.ly/4dqEXzF

Are you prepared for a revolution of GLP-1s in chronic care? Join an upcoming webinar to discover: 🔹 What new indications for GLP-1s are being studied 🔹 If the expansion will impact employer coverage 🔹 Strategies for 2025 benefits planning buff.ly/4dqEXzF

Thank you Alaska Department of Health for teaming up with Omada Health on the Fresh Start Campaign. We should both feel proud about the innovative work we’re doing to help people in remote areas. Learn more: buff.ly/3YQsCRg

Hats off to the team at Omada Health for over 10 years of advocacy to expand Medicare access to Diabetes Prevention Programs (DPP). While the finish line is still ahead, the win highlighted in this article is a significant milestone. Fun fact: years ago, my Co-founder Adrian

Curious about the economic impact if Medicare were to cover GLP-1s for Obesity? Yesterday, the Congressional Budget Office (CBO) — a nonpartisan agency that provides budgetary analysis for Congress — issued a report on the potential costs and benefits of Medicare covering

To all future air travelers: No, I didn't personally delay your flight. That's the OTHER Sean Duffy. 😉 axios.com/2024/11/18/tru…

What can the global market learn from the U.S. about GLP-1s? Omada CEO @SeanDuffy wrote about this in collaboration with @WEF to coincide with his participation at the annual meeting in Davos, Switzerland. Read it here: tinyurl.com/8m8cw8na